Registro:

Referencias:

• Vousden, K.H., Lu, X., Live or let die: The cell's response to p53 (2002) Nat Rev Cancer, 2, pp. 594-604
• Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours (1992) Nature, 356, pp. 215-221
• Vogelstein, B., Lane, D., Levine, A.J., Surfing the p53 network (2000) Nature, 408, pp. 307-310
• Kubbutat, M.H., Jones, S.N., Vousden, K.H., Regulation of p53 stability by Mdm2 (1997) Nature, 387, pp. 299-303
• Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., Vogelstein, B., Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 (1993) Nature, 362, pp. 857-860
• Shvarts, A., Steegenga, W.T., Riteco, N., Van Laar, T., Dekker, P., Bazuine, M., MDMX: A novel p53-binding protein with some functional properties of MDM2 (1996) Embo J, 15, pp. 5349-5357
• Jones, S.N., Roe, A.E., Donehower, L.A., Bradley, A., Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 (1995) Nature, 378, pp. 206-208
• Migliorini, D., Denchi, E.L., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development (2002) Mol Cell Biol, 22, pp. 5527-5538
• Montes De Oca Luna, R., Wagner, D.S., Lozano, G., Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 (1995) Nature, 378, pp. 203-206
• Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L., Vogelstein, B., Amplification of a gene encoding a p53-associated protein in human sarcomas (1992) Nature, 358, pp. 80-83
• Manfredi, J.J., The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor (2010) Genes Dev, 24, pp. 1580-1589
• Brown, D.R., Thomas, C.A., Deb, S.P., The human oncoprotein MDM2 arrests the cell cycle: Elimination of its cell-cycle-inhibitory function induces tumorigenesis (1998) Embo J, 17, pp. 2513-2525
• Dang, J., Kuo, M.L., Eischen, C.M., Stepanova, L., Sherr, C.J., Roussel, M.F., The RING domain of Mdm2 can inhibit cell proliferation (2002) Cancer Res, 62, pp. 1222-1230
• Folberg-Blum, A., Sapir, A., Shilo, B.Z., Oren, M., Overexpression of mouse Mdm2 induces developmental phenotypes in Drosophila (2002) Oncogene, 21, pp. 2413-2417
• Lundgren, K., Montes De Oca Luna, R., McNeill, Y.B., Emerick, E.P., Spencer, B., Barfield, C.R., Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53 (1997) Genes Dev, 11, pp. 714-725
• Ohkubo, S., Tanaka, T., Taya, Y., Kitazato, K., Prives, C., Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53 dependent transcription (2006) J Biol Chem, 281, pp. 16943-16950
• Zhou, R., Frum, R., Deb, S., Deb, S.P., The growth arrest function of the human oncoprotein mouse double minute-2 is disabled by downstream mutation in cancer cells (2005) Cancer Res, 65, pp. 1839-1848
• Piwnica-Worms, H., Cell cycle. Fools rush in (1999) Nature, 401, p. 537
• Imbriano, C., Gurtner, A., Cocchiarella, F., Di Agostino, S., Basile, V., Gostissa, M., Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters (2005) Mol Cell Biol, 25, pp. 3737-3751
• Le Gac, G., Esteve, P.O., Ferec, C., Pradhan, S., DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (Cytosine-5) methyltransferase 1 (2006) J Biol Chem, 281, pp. 24161-24170
• Lohr, K., Moritz, C., Contente, A., Dobbelstein, M., P21/CDKN1A Mediates Negative Regulation of Transcription by p53 (2003) J Biol Chem, 278, pp. 32507-32516
• Manni, I., Mazzaro, G., Gurtner, A., Mantovani, R., Haugwitz, U., Krause, K., NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest (2001) J Biol Chem, 276, pp. 5570-5576
• St Clair, S., Giono, L., Varmeh-Ziaie, S., Resnick-Silverman, L., Liu, W.J., Padi, A., DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: One involves direct binding to the cdc25C promoter (2004) Mol Cell, 16, pp. 725-736
• Badie, C., Itzhaki, J.E., Sullivan, M.J., Carpenter, A.J., Porter, A.C., Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells (2000) Mol Cell Biol, 20, pp. 2358-2366
• St Clair, S., Manfredi, J.J., The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53 (2006) Cell Cycle, 5, pp. 709-713
• Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 (2004) Science, 303, pp. 844-848
• Giono, L.E., Manfredi, J.J., Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest (2007) Mol Cell Biol, 27, pp. 4166-4178
• Pines, J., Hunter, T., Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 (1989) Cell, 58, pp. 833-846
• Innocente, S.A., Abrahamson, J.L., Cogswell, J.P., Lee, J.M., P53 regulates a G2 check-point through cyclin B1 (1999) Proc Natl Acad Sci USA, 96, pp. 2147-2152
• Jin, Y., Lee, H., Zeng, S.X., Dai, M.S., Lu, H., MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation (2003) Embo J, 22, pp. 6365-6377
• Singh, S.V., Herman-Antosiewicz, A., Singh, A.V., Lew, K.L., Srivastava, S.K., Kamath, R., Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C (2004) J Biol Chem, 279, pp. 25813-25822
• Xu, H., Zhang, Z., Li, M., Zhang, R., MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change (2010) J Biol Chem, 285, pp. 18407-18414
• Chin, L., Pomerantz, J., Depinho, R.A., The INK4a/ARF tumor suppressor: One gene-two products--two pathways (1998) Trends Biochem Sci, 23, pp. 291-296
• Zhang, Y., Xiong, Y., Yarbrough, W.G., ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways (1998) Cell, 92, pp. 725-734
• Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H., Weissman, A.M., Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 (2000) J Biol Chem, 275, pp. 8945-8951
• Honda, R., Tanaka, H., Yasuda, H., Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 (1997) FEBS Lett, 420, pp. 25-27
• Peng, C.Y., Graves, P.R., Thoma, R.S., Wu, Z., Shaw, A.S., Piwnica-Worms, H., Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 (1997) Science, 277, pp. 1501-1505
• Graves, P.R., Lovly, C.M., Uy, G.L., Piwnica-Worms, H., Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding (2001) Oncogene, 20, pp. 1839-1851
• Turowski, P., Franckhauser, C., Morris, M.C., Vaglio, P., Fernandez, A., Lamb, N.J., Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells (2003) Mol Biol Cell, 14, pp. 2984-2998
• Chen, F., Zhang, Z., Bower, J., Lu, Y., Leonard, S.S., Ding, M., Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway (2002) Proc Natl Acad Sci USA, 99, pp. 1990-1995
• Xiao, D., Johnson, C.S., Trump, D.L., Singh, S.V., Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells (2004) Mol Cancer Ther, 3, pp. 567-575
• Vecchione, A., Baldassarre, G., Ishii, H., Nicoloso, M.S., Belletti, B., Petrocca, F., Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development (2007) Cancer Cell, 11, pp. 275-289
• Sdek, P., Ying, H., Chang, D.L., Qiu, W., Zheng, H., Touitou, R., MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein (2005) Mol Cell, 20, pp. 699-708
• Chowdary, D.R., Dermody, J.J., Jha, K.K., Ozer, H.L., Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway (1994) Mol Cell Biol, 14, pp. 1997-2003
• Asher, G., Lotem, J., Sachs, L., Kahana, C., Shaul, Y., Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 (2002) Proc Natl Acad Sci USA, 99, pp. 13125-13130
• Bendjennat, M., Boulaire, J., Jascur, T., Brickner, H., Barbier, V., Sarasin, A., UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair (2003) Cell, 114, pp. 599-610
• Chen, X., Chi, Y., Bloecher, A., Aebersold, R., Clurman, B.E., Roberts, J.M., N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1) (2004) Mol Cell, 16, pp. 839-847
• Kong, X., Lin, Z., Liang, D., Fath, D., Sang, N., Caro, J., Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha (2006) Mol Cell Biol, 26, pp. 2019-2028
• Kawai, H., Wiederschain, D., Kitao, H., Stuart, J., Tsai, K.K., Yuan, Z.M., DNA damage-induced MDMX degradation is mediated by MDM2 (2003) J Biol Chem, 278, pp. 45946-45953
• Donzelli, M., Draetta, G.F., Regulating mammalian checkpoints through Cdc25 inactivation (2003) EMBO Rep, 4, pp. 671-677
• Mailand, N., Falck, J., Lukas, C., Syljuasen, R.G., Welcker, M., Bartek, J., Rapid destruction of human Cdc25A in response to DNA damage (2000) Science, 288, pp. 1425-1429
• Wang, X., McGowan, C.H., Zhao, M., He, L., Downey, J.S., Fearns, C., Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest (2000) Mol Cell Biol, 20, pp. 4543-4552
• Graves, P.R., Yu, L., Schwarz, J.K., Gales, J., Sausville, E.A., O'connor, P.M., The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01 (2000) J Biol Chem, 275, pp. 5600-5605
• Liu, T.T., Liu, Y.J., Wang, Q., Yang, X.G., Wang, K., Reactive-oxygen-species-mediated Cdc25C degradation results in differential antiproliferative activities of vanadate, tungstate, and molybdate in the PC-3 human prostate cancer cell line (2012) J Biol Inorg Chem, 17, pp. 311-320
• Raj, K., Ogston, P., Beard, P., Virus-mediated killing of cells that lack p53 activity (2001) Nature, 412, pp. 914-917
• Eymin, B., Claverie, P., Salon, C., Brambilla, C., Brambilla, E., Gazzeri, S., P14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation (2006) Cell Cycle, 5, pp. 759-765
• Thanasoula, M., Escandell, J.M., Suwaki, N., Tarsounas, M., ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres (2012) Embo J, 31, pp. 3398-3410
• Shabbeer, S., Omer, D., Berneman, D., Weitzman, O., Alpaugh, A., Pietraszkiewicz, A., BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation (2013) Oncogene, 32, pp. 5005-5016
• Yan, Y., Spieker, R.S., Kim, M., Stoeger, S.M., Cowan, K.H., BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation (2005) Oncogene, 24, pp. 3285-3296
• Burri, N., Shaw, P., Bouzourene, H., Sordat, I., Sordat, B., Gillet, M., Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer (2001) Lab Invest, 81, pp. 217-229
• Stott, F.J., Bates, S., James, M.C., McConnell, B.B., Starborg, M., Brookes, S., The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2 (1998) Embo J, 17, pp. 5001-5014
• Boyd, M.T., Vlatkovic, N., Haines, D.S., A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2 (2000) J Biol Chem, 275, pp. 31883-31890
• Ciznadija, D., Zhu, X.H., Koff, A., Hdm2-and proteasome-dependent turnover limits p21 accumulation during S phase (2011) Cell Cycle, 10, pp. 2714-2723
• Loughran, O., La Thangue, N.B., Apoptotic and growth-promoting activity of E2F modulated by MDM2 (2000) Mol Cell Biol, 20, pp. 2186-2197
• Uchida, C., Miwa, S., Kitagawa, K., Hattori, T., Isobe, T., Otani, S., Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation (2005) Embo J, 24, pp. 160-169
• Wang, B., Liu, K., Lin, H.Y., Bellam, N., Ling, S., Lin, W.C., 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer (2010) Mol Cell Biol, 30, pp. 1508-1527
• Zhang, Z., Wang, H., Li, M., Agrawal, S., Chen, X., Zhang, R., MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53 (2004) J Biol Chem, 279, pp. 16000-16006
• Evans, S.C., Viswanathan, M., Grier, J.D., Narayana, M., El-Naggar, A.K., Lozano, G., An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2 (2001) Oncogene, 20, pp. 4041-4049
• Perry, M.E., Mendrysa, S.M., Saucedo, L.J., Tannous, P., Holubar, M., P76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53 (2000) J Biol Chem, 275, pp. 5733-5738
• Calabro, V., Mansueto, G., Parisi, T., Vivo, M., Calogero, R.A., La Mantia, G., The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63 (2002) J Biol Chem, 277, pp. 2674-2681
• Kadakia, M., Slader, C., Berberich, S.J., Regulation of p63 function by Mdm2 and MdmX (2001) DNA Cell Biol, 20, pp. 321-330
• Little, N.A., Jochemsen, A.G., Hdmx and Mdm2 can repress transcription activation by p53 but not by p63 (2001) Oncogene, 20, pp. 4576-4580
• Ongkeko, W.M., Wang, X.Q., Siu, W.Y., Lau, A.W., Yamashita, K., Harris, A.L., MDM2 and MDMX bind and stabilize the p53-related protein p73 (1999) Curr Biol, 9, pp. 829-832
• Girnita, L., Girnita, A., Larsson, O., Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor (2003) Proc Natl Acad Sci USA, 100, pp. 8247-8252
• Pan, Y., Chen, J., MDM2 promotes ubiquitination and degradation of MDMX (2003) Mol Cell Biol, 23, pp. 5113-5121
• Coutts, A.S., Boulahbel, H., Graham, A., La Thangue, N.B., Mdm2 targets the p53 transcription cofactor JMY for degradation (2007) EMBO Rep, 8, pp. 84-90
• Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis (2007) Mol Cell, 25, pp. 739-750
• Shmueli, A., Oren, M., Mdm2: P53’s Lifesaver? (2007) Mol Cell, 25, pp. 794-796
• Sudo, T., Ota, Y., Kotani, S., Nakao, M., Takami, Y., Takeda, S., Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells (2001) Embo J, 20, pp. 6499-6508
• Obeyesekere, M.N., Tecarro, E., Lozano, G., Model predictions of MDM2 mediated cell regulation (2004) Cell Cycle, 3, pp. 655-661
• Garcia, P., Cales, C., Endoreplication in megakaryoblastic cell lines is accompanied by sustained expression of G1/S cyclins and downregulation of cdc25C (1996) Oncogene, 13, pp. 695-703
• Varmeh-Ziaie, S., Manfredi, J.J., The dual-specificity phosphatase Cdc25B, but not the closely related Cdc25C, is capable of inhibiting cellular proliferation in a manner dependent upon its catalytic activity (2007) J Biol Chem, 282, pp. 24633-24641

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------